MEIRAGTX Trademark

Trademark Overview


On Thursday, January 30, 2025, a trademark application was filed for MEIRAGTX with the United States Patent and Trademark Office. The USPTO has given the MEIRAGTX trademark a serial number of 99023559. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, October 15, 2025. This trademark is owned by MeiraGTx Limited. The MEIRAGTX trademark is filed in the Chemical Products, Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

Custom manufacture of human therapeutics, pharmaceuticals, biologicals and biopharmaceuticals

pharmaceutical products for use in gene therapy; pharmaceutical preparations and substances for the treatment of neurological and neurodegerative diseases, ocular diseases and rare diseases, in the nature of rare kidney diseases, rare cardiovascular diseases, rare hepato-gastro-enterological diseases, rare immunodeficiencies, developmental defects, neuromuscular diseases, rare neurological diseases, rare cardiovascular diseases, rare lung diseases, rare bone diseases, rare sensory disorders, rare skin diseases, rare diseases of connective tissue, rare endocrine diseases, rare hereditary metabolic diseases, rare nonmalignant hematologic disorder, salivary gland conditions, oncology, autoimmune conditions, ageing, metabolic disease, obesity ; auxiliary agents for pharmaceutical preparations, namely, small molecule compounds for use as drug delivery agents in pharmaceuticals; carriers for pharmaceutical preparations, namely, drug delivery agents consisting of compounds that facilitate del...

chemical additives, namely, chemical auxiliary agents, carriers, and substances, all for use in the manufacture of pharmaceutical preparations

scientific research in the field of genetics, gene therapy and genetic engineering; genetic testing for scientific research purposes; scientific advisory services relating to gene therapy research; scientific, biological, pharmaceutical and medical research services; laboratory research in the fields of genetics, drug development, biotechnology, microbiology and molecular biology; biochemical and biotechnological analysis services
meiragtx

General Information


Serial Number99023559
Word MarkMEIRAGTX
Filing DateThursday, January 30, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateWednesday, October 15, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesCustom manufacture of human therapeutics, pharmaceuticals, biologicals and biopharmaceuticals
Goods and Servicespharmaceutical products for use in gene therapy; pharmaceutical preparations and substances for the treatment of neurological and neurodegerative diseases, ocular diseases and rare diseases, in the nature of rare kidney diseases, rare cardiovascular diseases, rare hepato-gastro-enterological diseases, rare immunodeficiencies, developmental defects, neuromuscular diseases, rare neurological diseases, rare cardiovascular diseases, rare lung diseases, rare bone diseases, rare sensory disorders, rare skin diseases, rare diseases of connective tissue, rare endocrine diseases, rare hereditary metabolic diseases, rare nonmalignant hematologic disorder, salivary gland conditions, oncology, autoimmune conditions, ageing, metabolic disease, obesity ; auxiliary agents for pharmaceutical preparations, namely, small molecule compounds for use as drug delivery agents in pharmaceuticals; carriers for pharmaceutical preparations, namely, drug delivery agents consisting of compounds that facilitate delivery of pharmaceuticals; and substances for pharmaceutical preparations, namely, namely, anti-infectives, anti-inflammatories, antibacterial pharmaceuticals, antibiotics, antifungal preparations, antivirals; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; dermatological pharmaceutical products; pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases, salivary gland conditions, oncology, autoimmune conditions, ageing, metabolic disease, obesity; biological preparations for use in cell cultures for medical purposes
Goods and Serviceschemical additives, namely, chemical auxiliary agents, carriers, and substances, all for use in the manufacture of pharmaceutical preparations
Goods and Servicesscientific research in the field of genetics, gene therapy and genetic engineering; genetic testing for scientific research purposes; scientific advisory services relating to gene therapy research; scientific, biological, pharmaceutical and medical research services; laboratory research in the fields of genetics, drug development, biotechnology, microbiology and molecular biology; biochemical and biotechnological analysis services

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, January 30, 2025
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 30, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, January 30, 2025
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 30, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMeiraGTx Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLondon N17NQ
GB

Trademark Events


Event DateEvent Description
Thursday, January 30, 2025APPLICATION FILING RECEIPT MAILED
Thursday, January 30, 2025NEW APPLICATION ENTERED
Thursday, July 10, 2025ASSIGNED TO EXAMINER
Monday, July 21, 2025NON-FINAL ACTION WRITTEN
Wednesday, October 15, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 15, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 15, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 21, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 1, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 21, 2025NON-FINAL ACTION E-MAILED